Internal Artery Infusion Chemotherapy for Breast Cancer at Medias Clinic Burghausen

At Medias Clinic in Burghausen, Germany, the approach to treating advanced or recurrent breast cancer shifts from a whole-body assault to a tactical, localized strike known as internal artery infusion. Led by Prof. Karl Aigner, the medical team bypasses the traditional intravenous route, which dilutes medication throughout the entire bloodstream, in favor of a direct line to the tumor. By navigating a catheter into the internal mammary or subclavian artery, the clinic delivers high-concentration chemotherapy agents directly into the breast's primary blood supply. This method allows cancer cells to be "soaked" in a drug concentration up to 70 times higher than in standard systemic chemotherapy, ensuring the maximum possible impact on the malignancy while it remains confined to the target region. The methodology is backed by decades of clinical observation and published research focusing on high-risk cases where standard treatments may have reached their limit. For patients with stage III and IV breast cancer, studies have shown that this targeted infusion can lead to substantial tumor regression. Research involving the clinic's regional techniques has documented objective response rates of 60% to 80% in patients with locally advanced disease. One of the most significant advantages of this approach is its ability to facilitate "downstaging. " By shrinking large, once-inoperable tumors through concentrated internal artery infusion, the clinic frequently enables patients to become candidates for radical mastectomy or breast-conserving surgery, often within just a few weeks of beginning the regimen. For many who visit Medias Clinic Burghausen, the ultimate goal of internal artery Infusion is "conversion. " This occurs when a tumor that was previously deemed inoperable due to its size or involvement with the chest wall shrinks enough to allow for a safe, successful surgical removal.